• OPEN AN ACCOUNT
Indian Indices
Nifty
25,795.15 -96.25
(-0.37%)
Sensex
84,211.88 -344.52
( -0.41%)
Bank Nifty
57,699.60 -378.45
( -0.65%)
Nifty IT
35,986.35 -92.30
( -0.26%)
Global Indices
Nasdaq
47,235.40 479.79
(1.03%)
Dow Jones
6,814.07 54.63
(0.81%)
Hang Seng
49,325.08 683.47
(1.41%)
Nikkei 225
9,645.62 67.05
(0.70%)
Forex
USD-INR
87.83 0.08
(0.09%)
EUR-INR
101.91 0.09
(0.09%)
GBP-INR
117.11 -0.04
(-0.03%)
JPY-INR
0.58 0.00
(-0.39%)

EQUITY - MARKET SCREENER

Mahindra & Mahindra Ltd
Industry :  Automobiles - Passenger Cars
BSE Code
ISIN Demat
Book Value()
500520
INE101A01026
495.4165346
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
M&M
33.83
450754.33
EPS(TTM)
Face Value()
Div & Yield %
107.14
5
0.67
 

Fredun Pharmaceuticals Ltd - Board Meeting Intimation for Prior Intimation Under Regulation 29 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015 As Amended (The SEBI LODR Regulations)
Sep 22,2025
Fredun Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/09/2025 inter alia to consider and approve Dear Sir/ Madam We wish to inform you that pursuant to Regulation 29(1)(d) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 a meeting of the board of directors (the 'Board') of Fredun Pharmaceuticals Limited (the 'Company') is scheduled to be held on Thursday 25th September 2025 to inter alia consider a proposal for issuance of equity shares and/or warrants by way of a preferential allotment in accordance with the provisions of the SEBI (Issue of Capital and Disclosure Requirements) Regulations 2018 and the Companies Act 2013 as amended subject to such regulatory/ statutory approvals as may be required. We request you to kindly take this on record and consider the above in accordance with Regulations 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 as amended.